Klus Pharma
Pharmaceuticals, 8 Clarke Dr Ste 4, Cranbury, New Jersey, 08512, United States, 11-50 Employees
Phone Number: 60********
Who is KLUS PHARMA
Founded in 2014 as a wholly owned subsidiary of Kelun Group and affiliated company of Kelun-Biotech, KLUS Pharma is committed to the discovery and development of advanced therapeutic biot...
Read More
-
Headquarters: 8 Clarke Dr Ste 4, Cranbury, New Jersey, 08512, United States
-
Date Founded: 2014
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from KLUS PHARMA
Klus Pharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Klus Pharma
Answer: Klus Pharma's headquarters are located at 8 Clarke Dr Ste 4, Cranbury, New Jersey, 08512, United States
Answer: Klus Pharma's phone number is 60********
Answer: Klus Pharma's official website is https://kluspharma.com
Answer: Klus Pharma's revenue is $1 Million to $5 Million
Answer: Klus Pharma's SIC: 2834
Answer: Klus Pharma has 11-50 employees
Answer: Klus Pharma is in Pharmaceuticals
Answer: Klus Pharma contact info: Phone number: 60******** Website: https://kluspharma.com
Answer: Founded in 2014 as a wholly owned subsidiary of Kelun Group and affiliated company of Kelun-Biotech, KLUS Pharma is committed to the discovery and development of advanced therapeutic biotechnologies. Our top priority is to address the needs of patients suffering from cancers, cardiovascular diseases, autoimmune diseases, and other severe disorders due to lack of effective treatments. Utilizing our innovative technology platforms of monoclonal antibodies, bi-specific antibodies, and Antibody-Drug Conjugates (ADCs), we have advanced multiple biologic programs into the clinical stage to treat these debilitating conditions. KLUS Pharma has streamlined antibody discovery and engineering capabilities, which enable a seamless transition from target discovery to product development. Our team of industry experts in immuno-oncology, immunology, and cardiology, can rapidly advance biological drug candidates from bench to market. KLUS Pharma has identified and assessed dozens of therapeutic targets and is currently conducting preclinical and clinical studies for more than 10 antibody-based therapeutics.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month